Lithium therapy for HIV-1 Associated Neurocognitive Impairment

OBJECTIVE: To assess lithium safety and tolerability and to explore its impact on cognition, function and neuroimaging biomarkers in HIV infected subjects with cognitive impairment. METHODS: Fifteen cognitively impaired HIV infected subjects were enrolled in this 10-week open-label study of lithium...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Schifitto, Giovanni, Zhong, Jianhui, Gill, David, Peterson, Derick R., Gaugh, Michelle D., Zhu, Tong, Tivarus, Madalina, Cruttenden, Kim, Maggirwar, Sanjay B., Gendelman, Howard E., Dewhurst, Stephen, Gelbard, Harris A.
Formato: Artigo
Idioma:Inglês
Publicado: 2009
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2747099/
https://ncbi.nlm.nih.gov/pubmed/19306230
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/13550280902758973
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares